Seres Therapeutics (MCRB) said Thursday it received a $50 million installment related to the sale of its VOWST business to Societe des Produits Nestle.
The company said in September that it received $175 million in gross proceeds and expects to receive two installment payments.
Seres said it expects the next installment of $25 million in July.
Current cash reserves and anticipated future deal payments are anticipated to extend the company's cash runway into Q1 2026, Seres added.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。